Multiple Sclerosis Clinical Trials in Houston

Showing 481-500 of 606 trials

Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy

NCT00448097

The purpose of this study is to differentiate between the administrations of Cetuximab alone vs. Cetuximab plus Docetaxel in the treatment of non-metastatic prostate cancer before the surgical removal of the prostate.

Prostatic Neoplasms

The Methodist Hospital Research Institute7 participantsStarted Feb 2007

Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer

NCT00448409

To evaluate the efficacy and safety of Trovax and GM-CSF in patients with prostate cancer.

Prostatic Neoplasms

The Methodist Hospital Research Institute27 participantsStarted May 2006

Houston, Texas, United States

TERMINATEDPhase 2< 1 mile

Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis

NCT00595920

The purpose of this study is to further evaluate the safety and efficacy of Tovaxin in the treatment of relapsing forms of multiple sclerosis.

Multiple Sclerosis, Relapsing-RemittingClinically Isolated Syndrome

Opexa Therapeutics, Inc.116 participantsStarted Nov 2007

Cullman, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +24 more locations

Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy

Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer

Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis

Multiple Sclerosis Trials in Other Cities

BAY1238097, First in Man

Understanding Sleep Problems in Children With Autism Spectrum Disorder

Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane

huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas

Safety and Tolerability of Glatiramer Acetate

A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Randomized Controlled Trial of Tailored Interactive Multimedia to Reduce Colorectal Cancer Screening Disparities

Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer

Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer

Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.

Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer

Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer

Gene Expression Profiles to Categorize Wilms Tumors

Study of Electrical Impedance Myography (EIM) in ALS

Other Conditions in Houston